Kraematon Investment Advisors, Inc Wave Life Sciences Ltd. Transaction History
Kraematon Investment Advisors, Inc
- $108 Million
- Q3 2025
A detailed history of Kraematon Investment Advisors, Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Kraematon Investment Advisors, Inc holds 13,450 shares of WVE stock, worth $92,939. This represents 0.09% of its overall portfolio holdings.
Number of Shares
13,450
Previous 19,360
30.53%
Holding current value
$92,939
Previous $125,000
23.2%
% of portfolio
0.09%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding WVE
# of Institutions
215Shares Held
133MCall Options Held
1.22MPut Options Held
616K-
Ra Capital Management, L.P. Boston, MA18.2MShares$126 Million2.25% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA14.6MShares$101 Million0.18% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.39MShares$58 Million0.89% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$46.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.3MShares$43.5 Million0.38% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $600M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...